Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL17 treatment: a clinical case

James L. et al, (2025), Rheumatology

Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL17 treatment: a clinical case

James L. et al, (2025), Rheumatology

Genetic determinants of monocyte splicing are enriched for disease susceptibility loci including for COVID-19

Fairfax B. et al, (2024)

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.

Worth C. et al, (2024), Lancet Rheumatol

A first in disease phase 2, randomised, controlled trial of Granulocyte-Macrophage Colony-Stimulating factor neutralisation for Axial Spondyloarthritis (NAMASTE study)

BOWNESS P., (2024), Lancet Rheumatology

Elevated type-17 cytokines are present in Axial Spondyloarthritis stool

BOWNESS P. and BROUGH I., (2024), Discovery Immunology

Include forthcoming?